Since May 2015, the AG Pro Biosimilars, which is under the umbrella of Pro Generika e.V., has been open to all biosimilar companies in Germany. The AG Pro Biosimilars is committed
to fair and sustainable competitive conditions for biosimilars. Because once these are in supply, all patients have access to the biopharmaceutical drug therapies they need.
